{ "cik": 873303, "cik_padded": "0000873303", "entityName": "Sarepta Therapeutics, Inc.", "fiscal_years": [ { "accn": "0001193125-26-084144", "filed": "2026-03-02", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 25013000.0, "capex": 101972000.0, "cash": 801282000.0, "eps_diluted": -7.13, "free_cash_flow": -307451000.0, "net_income": -713410000.0, "operating_cash_flow": -205479000.0, "operating_income": -699781000.0, "revenue": 2198237000.0, "stockholders_equity": 1140622000.0, "total_assets": 3349703000.0, "total_liabilities": 2209081000.0 }, "period_end": "2025-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.9367336418199894, "net_margin": -0.3245373451543215, "operating_margin": -0.3183373767250756, "revenue_growth_yoy": 0.1557630236716599, "roa_avg2y": -0.19511065140445427, "roa_period_end": -0.21297709080476687, "roe_avg2y": -0.5347171525324131, "roe_period_end": -0.6254569875033096 } }, { "accn": "0001193125-26-084144", "filed": "2026-03-02", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 0.0, "capex": 136956000.0, "cash": 1103010000.0, "eps_diluted": 2.34, "free_cash_flow": -342743000.0, "net_income": 235239000.0, "operating_cash_flow": -205787000.0, "operating_income": 218081000.0, "revenue": 1901979000.0, "stockholders_equity": 1527742000.0, "total_assets": 3963173000.0, "total_liabilities": 2435431000.0 }, "period_end": "2024-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.594137622713783, "net_margin": 0.12368117629058997, "operating_margin": 0.11466004619399058, "revenue_growth_yoy": 0.5297385421157274, "roa_avg2y": 0.0650932952984394, "roa_period_end": 0.059356227951694256, "roe_avg2y": 0.197093602683447, "roe_period_end": 0.15397822407186554 } }, { "accn": "0001193125-26-084144", "filed": "2026-03-02", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 0.0, "capex": 76106000.0, "cash": 428430000.0, "eps_diluted": -5.8, "free_cash_flow": -577099000.0, "net_income": -535977000.0, "operating_cash_flow": -500993000.0, "operating_income": -267824000.0, "revenue": 1243336000.0, "stockholders_equity": 859337000.0, "total_assets": 3264576000.0, "total_liabilities": 2405239000.0 }, "period_end": "2023-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 2.7989473279982127, "net_margin": -0.43107977248306173, "operating_margin": -0.21540758089526885, "revenue_growth_yoy": 0.3326030827008841, "roa_avg2y": -0.16767772959617028, "roa_period_end": -0.1641796668235017, "roe_avg2y": -0.8615006023529941, "roe_period_end": -0.6237099065907787 } }, { "accn": "0001193125-26-084144", "filed": "2026-03-02", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 30824000.0, "cash": 966777000.0, "eps_diluted": -8.03, "free_cash_flow": -356170000.0, "net_income": -703488000.0, "operating_cash_flow": -325346000.0, "operating_income": -536201000.0, "revenue": 933013000.0, "stockholders_equity": 384950000.0, "total_assets": 3128366000.0, "total_liabilities": 2743416000.0 }, "period_end": "2022-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 7.126681387193142, "net_margin": -0.7539959250299835, "operating_margin": -0.5746983161006332, "revenue_growth_yoy": 0.32929232198345315, "roa_avg2y": -0.2241714120012619, "roa_period_end": -0.22487394377767822, "roe_avg2y": -1.0716069580238226, "roe_period_end": -1.8274788933627744 } }, { "accn": "0000950170-25-029973", "filed": "2025-02-28", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 38490000.0, "cash": 2115869000.0, "eps_diluted": -5.15, "free_cash_flow": -481662000.0, "net_income": -418780000.0, "operating_cash_flow": -443172000.0, "operating_income": -459710000.0, "revenue": 701887000.0, "stockholders_equity": 928009000.0, "total_assets": 3147974000.0, "total_liabilities": 2219965000.0 }, "period_end": "2021-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 2.392180463767054, "net_margin": -0.5966487483027895, "operating_margin": -0.6549629783711624, "revenue_growth_yoy": 0.29955248945100804, "roa_avg2y": -0.13657297643514463, "roa_period_end": -0.1330315942888982, "roe_avg2y": -0.4956656771817196, "roe_period_end": -0.45126717521058524 } }, { "accn": "0000950170-24-022036", "filed": "2024-02-28", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 82202000.0, "cash": 1502648000.0, "eps_diluted": -7.11, "free_cash_flow": 25264000.0, "net_income": -554128000.0, "operating_cash_flow": 107466000.0, "operating_income": -564163000.0, "revenue": 540099000.0, "stockholders_equity": 761759000.0, "total_assets": 2984718000.0, "total_liabilities": 2222959000.0 }, "period_end": "2020-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 2.9181919741020454, "net_margin": -1.025974867570575, "operating_margin": -1.044554794583956, "revenue_growth_yoy": 0.41820430477400855, "roa_avg2y": -0.23052455101777625, "roa_period_end": -0.18565506021004333, "roe_avg2y": -0.7014518217711239, "roe_period_end": -0.7274321668664236 } }, { "accn": "0001564590-21-009835", "filed": "2023-02-28", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 59631000.0, "cash": 835080000.0, "free_cash_flow": -516094000.0, "net_income": -715075000.0, "operating_cash_flow": -456463000.0, "operating_income": -705563000.0, "revenue": 380833000.0, "stockholders_equity": 818187000.0, "total_assets": 1822822000.0, "total_liabilities": 1004635000.0 }, "period_end": "2019-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.2278794456523998, "revenue_growth_yoy": 0.265083013878831, "roa_avg2y": -0.4127539721959989, "roa_period_end": -0.3922900864703191, "roe_avg2y": -0.7728606300152989, "roe_period_end": -0.8739750203804264 } }, { "accn": "0001564590-21-009835", "filed": "2022-03-01", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 61157000.0, "cash": 370829000.0, "free_cash_flow": -449817000.0, "net_income": -361918000.0, "operating_cash_flow": -388660000.0, "operating_income": -343628000.0, "revenue": 301034000.0, "stockholders_equity": 1032276000.0, "total_assets": 1642075000.0, "total_liabilities": 609799000.0 }, "period_end": "2018-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.5907325172725124, "net_margin": -1.202249579781686, "operating_margin": -1.1414923231262915, "revenue_growth_yoy": 0.9473813590022253, "roa_avg2y": -0.24536489178617638, "roa_period_end": -0.22040284396266918, "roe_avg2y": -0.3973861003034324, "roe_period_end": -0.3506019707907575 } }, { "accn": "0001564590-21-009835", "filed": "2021-03-01", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 12000000.0, "cash": 599691000.0, "free_cash_flow": -243996000.0, "net_income": -50688000.0, "operating_cash_flow": -231996000.0, "operating_income": -171638000.0, "revenue": 154584000.0, "stockholders_equity": 789217000.0, "total_assets": 1307964000.0, "total_liabilities": 518747000.0 }, "period_end": "2017-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.6572932412758469, "net_margin": -0.327899394503959, "operating_margin": -1.1103218961858925, "revenue_growth_yoy": 27.515771997786388, "roa_avg2y": -0.05852887992850165, "roa_period_end": -0.038753360184225254, "roe_avg2y": -0.0900393282577262, "roe_period_end": -0.06422568191004502 } }, { "accn": "0001564590-20-006769", "filed": "2020-02-26", "fiscal_year": 2016, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 5341000.0, "cash": 122420000.0, "free_cash_flow": -251161000.0, "net_income": -267265000.0, "operating_cash_flow": -245820000.0, "operating_income": -266730000.0, "revenue": 5421000.0, "stockholders_equity": 336691000.0, "total_assets": 424104000.0, "total_liabilities": 87413000.0 }, "period_end": "2016-12-31", "ratio_units": { "leverage": "ratio", "roa_period_end": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.25962380936823376, "roa_period_end": -0.6301874068624677, "roe_period_end": -0.7937990620479906 } }, { "accn": "0001193125-12-112142", "filed": "2012-03-13", "fiscal_year": 2011, "form": "10-K", "fundamental_units": { "eps_diluted": "USD/shares" }, "fundamentals": { "eps_diluted": -0.02 }, "period_end": "2011-12-31", "ratios": {} }, { "accn": "0001193125-12-112142", "filed": "2012-03-13", "fiscal_year": 2010, "form": "10-K", "fundamental_units": { "eps_diluted": "USD/shares" }, "fundamentals": { "eps_diluted": -0.29 }, "period_end": "2010-12-31", "ratios": {} }, { "accn": "0001193125-12-112142", "filed": "2012-03-13", "fiscal_year": 2009, "form": "10-K", "fundamental_units": { "eps_diluted": "USD/shares" }, "fundamentals": { "eps_diluted": -0.27 }, "period_end": "2009-12-31", "ratios": {} } ], "latest_filing": { "accn": "0001193125-26-084144", "filed": "2026-03-02", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2834", "sic_description": "Pharmaceutical Preparations", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0000873303.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0000873303.json" }, "ticker": "SRPT" }